Home500124 • BOM
Dr Reddy's Laboratories Ltd
₹1,215.35
Nov 22, 4:00:00 PM GMT+5:30 · INR · BOM · Disclaimer
StockIN listed securityIN headquartered
Previous close
₹1,194.55
Day range
₹1,194.00 - ₹1,222.85
Year range
₹1,074.35 - ₹1,420.20
Market cap
1.01T INR
Avg Volume
59.31K
P/E ratio
18.98
Dividend yield
0.66%
Primary exchange
NSE
CDP Climate Change Score
A-
Financials
Income Statement
Revenue
Net income
(INR)Sep 2024Y/Y change
Revenue
80.16B16.51%
Operating expense
29.72B24.54%
Net income
12.55B-15.18%
Net profit margin
15.66-27.20%
Earnings per share
15.83-11.13%
EBITDA
22.02B8.53%
Effective tax rate
30.01%
Total assets
Total liabilities
(INR)Sep 2024Y/Y change
Cash and short-term investments
63.07B-7.15%
Total assets
465.96B34.27%
Total liabilities
156.67B66.79%
Total equity
309.28B
Shares outstanding
833.05M
Price to book
3.26
Return on assets
10.24%
Return on capital
13.21%
Net change in cash
(INR)Sep 2024Y/Y change
Net income
12.55B-15.18%
Cash from operations
9.32B-48.03%
Cash from investing
-19.07B-322.21%
Cash from financing
16.15B329.53%
Net change in cash
6.37B1.03%
Free cash flow
3.92B-72.47%
About
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr. Wikipedia
Founded
1984
Employees
27,048
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu